07/01/2021 7:36 PM
Clarín.com
Politics
Updated 07/01/2021 19:59
The President of the Nation has a Decree of Necessity and Urgency ready to sign in the next few hours that would
enable the arrival in the country
of
Pfizer
,
Moderna
and
Jansen
vaccines
, according to
important government sources
confirmed to
Clarín
.
The Decree, as two members of the team closest to the President assured this newspaper, is intended to modify the paragraphs of the Vaccine Law objected to by the US laboratory Pfizer and that prevented the signing of the contract with that company for the purchase of vaccines against the Coronavirus.
"Alberto got tired of going back and forth with the American laboratories. That negotiation was not interrupted but it
was bogged down
, and the President made the decision to advance by decree," one of those officials told this newspaper.
This Tuesday, the presidential adviser in charge of negotiating the purchase of vaccines with foreign laboratories,
Cecilia Nicolini
, met for several hours at the Casa Rosada with the Minister of Health,
Carla Vizzotti
, and the Legal and Technical Secretary of the Presidency,
Vilma Ibarra
.
The first objective of the Government is to
unblock the arrival to the country of the vaccines donated by the United States government
.
Last month, the
Joe Biden
administration
announced that it would donate millions of Pfizer, Moderna and Jansen vaccines to several countries around the world, including Argentina, but warned that each country should be responsible for adapting its legal frameworks so that the donation.
Until today, in Argentina, the legal frameworks are not ready for various reasons.
Pfizer's vaccine is approved by the National Administration of Medicines, Food and Medical Technology (ANMAT), but the company refused to sign the contract with Argentina because they argue that the Vaccine Law that Congress approved last year could generate to the laboratory, lawsuits arising from the application of a vaccine that was developed and tested with the emergencies imposed by the pandemic.
In the case of Moderna and Jansen, who had very preliminary dialogues with the government, they have not yet received full authorization from ANMAT.
